Drug recall · June 19, 2019
Heparin Sodium 25 recall
Why: Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018-3524 USA, API from SPAIN, NDC 0264-9587-20.
- Lots / codes
Lot #: J7B259, Exp 31 Aug 2019
- Quantity
- 40,176 bags
- Company
- B. Braun Medical Inc, Irvine, CA
- Distribution
- Nationwide in the USA
- Initiated
- June 13, 2019 · Voluntary: Firm initiated
- Classified
- June 13, 2019
- Reported
- June 19, 2019
- Ended
- July 15, 2022
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.